Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 7

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 7
---
 Internet website at www.inmunebio.com. The
information contained on, connected to or that can be accessed via our website is not part of this reoffer prospectus and should not be
relied upon in connection with making any decision with respect to an investment in our securities. We are required to file annual, quarterly
and current reports, proxy statements and other information with the SEC. You may obtain any of the documents filed by us with the SEC
at no cost from the SEC’s website at http://www.sec.gov.

About This Offering

This offering relates to the resale by the selling stockholders of
up to 1,592,000 and 1,732,550 shares of common stock issued or issuable upon exercise of options issued pursuant to grants made pursuant
to our 2017 Plan and 2019 Plan, respectively. If, subsequent to the date of this reoffer prospectus, we grant additional shares of common
stock to the selling stockholders or to other affiliates under the 2017 Plan and 2019 Plan, we may supplement this reoffer prospectus
to reflect such additional shares to the selling stockholders and/or the names of such affiliates and the number of shares to be reoffered
by them under the 2017 Plan and 2019 Plan. Subject to the satisfaction of any conditions to vesting of the shares of common stock offered
hereby pursuant to the terms of the relevant award agreements, the selling stockholders may from time to time sell, transfer or otherwise
dispose of any or all of the shares of common stock covered by this reoffer prospectus through underwriters or dealers, directly to purchasers
(or a single purchaser) or through broker-dealers or agents. We will not receive any proceeds from the sale of common stock by the selling
stockholders. The selling stockholders will bear all sales commissions and similar expenses. We will bear all expenses of registration
incurred in connection with this offering, including any other expenses incurred by us in connection with the registration and offering
that are not borne by the selling stockholders.

<div align='center'>1

RISK FACTORS</div>

Investing in our securities involves a high degree
of risk. Before making an investment decision, you should consider carefully the risks, uncertainties and other factors described in our
most recently filed Annual Report on Form 10-K, our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K that we
have filed or will file with